Neuren Pharmaceuticals Limited (NURPF)
OTC Markets OTCPK - OTC Markets OTCPK Delayed Price. Currency in USD
Add to watchlist
As of 09:44AM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 1.66B |
| Enterprise Value | 1.51B |
| Trailing P/E | 15.88 |
| Forward P/E | 35.34 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 10.75 |
| Price/Book (mrq) | 12.08 |
| Enterprise Value/Revenue | 9.83 |
| Enterprise Value/EBITDA | 11.45 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 2.03 |
| 52-Week Change 3 | 42.21% |
| S&P500 52-Week Change 3 | 23.23% |
| 52 Week High 3 | 17.20 |
| 52 Week Low 3 | 6.17 |
| 50-Day Moving Average 3 | 13.12 |
| 200-Day Moving Average 3 | 11.92 |
Share Statistics
| Avg Vol (3 month) 3 | 210 |
| Avg Vol (10 day) 3 | 599 |
| Shares Outstanding 5 | 129.95M |
| Implied Shares Outstanding 6 | 132.68M |
| Float 8 | 108.84M |
| % Held by Insiders 1 | 13.31% |
| % Held by Institutions 1 | 17.30% |
| Shares Short 4 | N/A |
| Short Ratio 4 | N/A |
| Short % of Float 4 | N/A |
| Short % of Shares Outstanding 4 | N/A |
| Shares Short (prior month ) 4 | N/A |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:20 |
| Last Split Date 3 | Nov 21, 2017 |
Financial Highlights
Currency in AUD.Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | 67.72% |
| Operating Margin (ttm) | 89.40% |
Management Effectiveness
| Return on Assets (ttm) | 85.52% |
| Return on Equity (ttm) | 127.30% |
Income Statement
| Revenue (ttm) | 231.94M |
| Revenue Per Share (ttm) | 1.83 |
| Quarterly Revenue Growth (yoy) | 996.30% |
| Gross Profit (ttm) | N/A |
| EBITDA | 199.26M |
| Net Income Avi to Common (ttm) | 157.08M |
| Diluted EPS (ttm) | 0.79 |
| Quarterly Earnings Growth (yoy) | 1,409.80% |
Balance Sheet
| Total Cash (mrq) | 228.54M |
| Total Cash Per Share (mrq) | 1.8 |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 5.78 |
| Book Value Per Share (mrq) | 1.61 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 184.92M |
| Levered Free Cash Flow (ttm) | 152.97M |
© 2024 Yahoo. All rights reserved.